|
Symbol
|
RMBFCV | RMBQSV | RMBRSV | RMBHZV | RMAMLV | ACGYSQ | RMAZIV | ACUCTQ | ACKJSQ | RMBYDV | ACZZSQ | ACVOSQ | AENPTQ | AETSTQ | RKPRCH | RMAUVV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Auto-Callable Multi Defender VONTI | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti |
|
Sous-jacent
|
AMS AG / Zur Rose Group AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | DOCMORRIS AG / Roche PS / Ypsomed Hldg. AG | DOCMORRIS AG / Galderma Group AG / Sandoz Group AG | DOCMORRIS AG / Novartis AG / Roche PS / Sandoz Group AG | DOCMORRIS AG / Roche PS | DOCMORRIS AG / Lonza Group N / Sandoz Group AG | DOCMORRIS AG / Novartis AG / Sandoz Group AG | DOCMORRIS AG / Lonza Group N / Sandoz Group AG | DOCMORRIS AG / Galenica AG / Tecan Group AG | Shop Apotheke Europe / Zur Rose Group AG | Novartis AG / Zur Rose Group AG | Straumann Hldg. AG / Zur Rose Group AG | DOCMORRIS AG / Stadler Rail AG | Bachem Hldg. AG / DOCMORRIS AG | DOCMORRIS AG / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
12.07.2027 | 18.05.2026 | 22.05.2026 | 17.07.2026 | 08.05.2026 | 24.06.2026 | 04.05.2026 | 29.10.2026 | 05.05.2026 | 05.10.2026 | 22.12.2026 | 29.09.2026 | 07.01.2027 | 13.11.2026 | 15.12.2026 | 14.05.2027 |
| Demande | - | 41,700 | - | 76,20 | 76,10 | 84,46 | - | - | - | 91,40 | 78,25 | 101,46 | 96,82 | 110,24 | 101,11 | 101,80 |
| Offre | - | - | - | - | - | - | - | - | - | 92,80 | - | 102,68 | 98,02 | 111,13 | 101,92 | 103,20 |